Abstract
The lipophilicity of a representative number of hydantoin derivatives was experimentally determined by RP-HPLC. The stationary phase of RP-HPLC proved a good model to simulate effects of membrane transport. These experimental values were correlated to theoretically estimated lipophilicity values on the basis of global minima structures of the compounds studied. Both these lipophilicity and structure similarities within a proposed pharmacological model for binding the hydantoin derivatives along the sodium channel were classified with respect to their biological activity.
Similar content being viewed by others
REFERENCES
Kleinpeter, E. Struct. Chem. 1997, 8, 161.
Elderfield, R. C. Heterocycl. Compd. 1957, 5, 254.
Seydel, J. K.; Schaper, K.-J. Chemische Struktur und Biologische Wirkung von Wirkstoffen, Methoden der quantitativen Struktur-Wirkungsanalyse; Verlag Chemie Weinheim; New York, 1979.
Braumann, T. J. Chromatogr. 1986, 373, 191.
Meldrum, B. S. Epilepsia 1997, 38(suppl. 9), 7.
Forth, W.; Henschler, D.; Rummel, W.; Starke, K. Allgemeine und spezielle Pharmakologie und Toxikologie, 6, Auflage; Wirtschaftsverlag Mannheim; Leipzig, Wien, Zürich, 1992.
Brouillette, W. J.; Brown, G. B.; DeLorey, T. M.; Liang, G. J. Pharm. Sci. 1990, 79, 871.
Brouillette, W. J.; Brown, G. B.; DeLorey, T. M.; Shirali, S. S.; Grunewald, G. L. J. Med. Chem. 1988, 31, 2218.
Brouillette, W. J.; Jestkov, V. P.; Brown, M. L.; Akhtar, M. S.; DeLorey, T. M.; Brown, G. B. J. Med. Chem. 1994, 37, 3289.
Unverferth, K.; Engel, J.; Höfgen, N.; Rostock, A.; Günther, R.; Lankau, H.-J.; Menzer, M.; Rolfs, A.; Liebscher, J.; Müller, B.; Hofmann, H.-J. J. Med. Chem. 1998, 41, 63.
Jones, G. L.; Woodbury, D. M. Principles of drug action: structure-activity relationships and mechanisms. In Antiepileptic Drugs; Woodbury, D. L.; Penry, J. K.; Pippenger, C. E. (Eds.); Raven Press; New York, 1982.
Jones, G. L.; Woodbury, D. M. Drug Dev. Res. 1982, 2, 333.
Codding, P. W.; Duke, N. E.; Aha, L. J.; Palmer, L. Y.; McClurg, D. K.; Szkaradzinska, M. B. Structural and computational studies of anticonvulsants. In Crystallogr. Model. Methods. Mol. Des. 1989; Bugg, E.; Ealick, M. (Eds.); Springer, New York, 1989.
Kleinpeter, E.; Heydenreich, M.; Kalder, L.; Koch, A.; Henning, D.; Kempter, G.; Benassi, R.; Taddei, F. J. Mol. Struct. 1997, 403, 111.
PrologP 5.1; compuDrug Ungarn, Manuel.
Rekker, R. F.; Mannhold, R. Calculation of Drug Lipophilicity; VCH Weinheim; New York, 1992.
Kubinyi, H. QSAR: Hansch analysis and related approaches. In Methods and Principles in Medicinal Chemistry, vol. 1; Mannhold, R.; Krogsgaard-Larsen, P.; Timmerman, H. (Eds.); VCH Weinheim, 1993, p. 126.
Seydel, J. K.; Cordes, H. P.; Albores-Valesco, M.; Visser, K.; Wiese, M. Methods and parameters to describe drug-membrane interaction and their use in QSAR. In Trends in QSAR and Molecular Modelling 92; Wermuth, C. G. (Ed.); ESCOM; Leiden, 1993.
Finkbeiner, H. L. J. Org. Chem. 1965, 30, 3414.
Bucherer, H. Th.; Lieb, V. A. J. Prakt. Chem. 1934, 141, 5.
Henze, H. R. J. Org. Chem. 1945, 10, 2.
Gagnon, P. E.; Boivin, J. L.; Boivin, P. A. Can. J. Res. Sect. B 1950, 28, 207.
Connors, T. A.; Ross, W. C. J. J. Chem. Soc. 1960, 2119.
Henze, H. R.; Speer, R. J. J. Am. Chem. Soc. 1942, 64, 522.
Nitz, R. E.; Persch, W.; Schmidt, A. Arzneim.-Forsch. 1955, 5, 357.
Abshire, C. J. Experientia 1968, 24, 778.
Novelli, A. An. Asoc. Quin. Arg. 1941, 29, 83.
Thompson, T. J.; Bredell, H. L.; Buffett, G. M. J. Am. Chem. Soc. 1925, 47, 875.
Thompson, T. J.; Bredell, H. L.; Buffett, G. M. J. Am. Chem. Soc. 1925, 47, 874.
Tiffenau, M.; Tchoubar, B.; Saias-Lambert. Bull. Soc. Chim. Fr. 1947, 4, 445.
Rogers, B. G.; Henze, H. R. J. Am. Chem. Soc. 1941, 63, 2190.
Dunnavant, W. R.; James, F. L. J. Am. Chem. Soc. 1956, 78, 2740.
Slotta, K. H.; Behnisch, R.; Szyzka, G. Ber. Dtsch. Chem. Ges. 1934, 67, 1529.
Goodson, L. H.; Honigberg, I. L.; Lehmann, J. J.; Burton, W. H. J. Org. Chem. 1960, 25, 1920.
Endler, A. S.; Becker, E. I. J. Am. Chem. Soc. 1954, 76, 6608.
Jitai Li; Lijum Li; Tongshuang Li; Jiankui Li. Ultrason. Sonochem. 1996, 3, 141.
Chem. Fabrik von der Heyden, DRP 335 993; C 1921, IV, 127.
Henze, H. R.; Isbell, A. F. J. Am. Chem. Soc. 1955, 77, 6608.
Stajer, G.; Nemeth, P.; Szabo, E. A.; Vinkler, E.; Sohar, P. Arch. Pharm. 1978, 311, 421.
Spurlock, J. J. J. Am. Chem. Soc. 1953, 75, 1115.
McLean, M. J.; Seeger, D. R. J. Am. Chem. Soc. 1940, 62, 1416.
Kozak, J.; Musial, L. Bull. Int. Acad. Pol. Sci. Lett., Cl. Sci. Nat., Ser. A 1930, 432.
Musial, L.; Staniec, J. Rocz. Chem. 1963, 37, 621.
Musial, L. Rocz. Chem. 1961, 35, 1651.
Musial, L. Rocz. Chem. 1958, 32, 1115.
Connolly, M. L. Science 1983, 221, 4612.
MOLCAD; Brickmann, J. TU Darmstadt.
Ghose, A.; Crippen, G. J. Comp. Chem. 1986, 7(4), 565.
SYBYL Molecular Modelling Software; Version 6.4; TRIPOS Inc.; St. Louis, Missouri, 1997.
Pihlaja, K.; Kleinpeter, E. Carbon-13 NMR Chemical Shifts in Structural and Stereochemical Analysis; VCH; New York, 1994.
Kwon, C.-H.; Igbal, M.-T.; Wurpel, J. N.-D. J. Med. Chem. 1991, 34, 1845.
Ciechanowicz-Rutkowska, M.; Ragona, L.; Greco, F.; Zetta, L.; Pegna, M. Magn. Res. Chem. 1995, 33, 586.
Löscher, W. Europ. J. Pharm. 1998, 342, 1.
Fletcher, R.; Powell, M. J. D. Comput. J. 1963, 6, 163.
Audry, E.; Dubost, J. P.; Colleter, J. C.; Dallet, P. Eur. J. Med. Chem.-Chim. Ther. 1986, 21, 71.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scholl, S., Koch, A., Henning, D. et al. The Influence of Structure and Lipophilicity of Hydantoin Derivatives on Anticonvulsant Activity. Structural Chemistry 10, 355–366 (1999). https://doi.org/10.1023/A:1022091411018
Issue Date:
DOI: https://doi.org/10.1023/A:1022091411018